The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Otrivine-Antistin Eye Drops

Laboratoires TheaPA1107/008/001

Main Information

Trade NameOtrivine-Antistin Eye Drops
Active SubstancesXylometazoline hydrochloride
Dosage FormEye drops, solution
Licence HolderLaboratoires Thea
Licence NumberPA1107/008/001

Group Information

ATC CodeS01GA Sympathomimetics used as decongestants
S01GA53 xylometazoline, combinations


License statusAuthorised
Licence Issued01/04/1983
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back